Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Class A Common Stock, par value $0.001 per share
- Shares outstanding
- 72,325,000
- Total 13F shares
- 39,258,779
- Share change
- +824,363
- Total reported value
- $538,195,352
- Put/Call ratio
- 0%
- Price per share
- $13.71
- Number of holders
- 84
- Value change
- +$9,620,413
- Number of buys
- 54
- Number of sells
- 23
Quarterly Holders Quick Answers
What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92337R101:
Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
9%
|
6,535,560
|
$104,895,739 | — | 30 Jun 2023 | |
| Commodore Capital LP |
13F
|
Company |
7.5%
|
5,450,000
|
$87,472,500 | — | 30 Jun 2023 | |
| Sofinnova Venture Partners X, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,467,156
|
$62,408,808 | — | 06 Feb 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
4.8%
|
3,467,156
|
$55,647,854 | — | 30 Jun 2023 | |
| Emster Kurt von |
3/4/5
|
Director |
—
mixed-class rows
|
2,987,984
mixed-class rows
|
$53,605,062 | — | 17 May 2021 | |
| Abingworth LLP |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
2,970,156
mixed-class rows
|
$53,284,158 | — | 13 May 2021 | |
| Carlyle Group Inc. |
3/4/5
13F
|
10%+ Owner · Company |
3.3%
from 13F
|
2,960,231
|
$53,284,158 | — | 17 Aug 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
4.1%
|
3,000,000
|
$48,150,000 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3%
|
2,170,134
|
$34,830,651 | — | 30 Jun 2023 | |
| Longitude Capital Partners IV, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,714,285
|
$30,857,130 | — | 06 Feb 2023 | |
| Longitude Prime Partners, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,714,285
|
$30,857,130 | — | 06 Feb 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.4%
|
1,756,800
|
$28,196,640 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
2.4%
|
1,753,690
|
$28,146,725 | — | 30 Jun 2023 | |
| Eversept Partners, LP |
13F
|
Company |
2.4%
|
1,740,951
|
$27,942,264 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
1,440,265
|
$23,116,253 | — | 30 Jun 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
1.3%
|
975,227
|
$15,642,641 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
968,045
|
$15,537,123 | — | 30 Jun 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.3%
|
919,352
|
$14,755,600 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
650,692
|
$10,443,606 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.8%
|
576,549
|
$9,253,611 | — | 30 Jun 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.49%
|
351,646
|
$5,643,918 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.46%
|
333,689
|
$5,355,708 | — | 30 Jun 2023 | |
| Alphabet Inc. |
13F
|
Company |
0.42%
|
301,580
|
$4,840,359 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
285,493
|
$4,582,163 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
277,463
|
$4,453,281 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.38%
|
274,610
|
$4,407,490 | — | 30 Jun 2023 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.36%
|
262,355
|
$4,210,798 | — | 30 Jun 2023 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.29%
|
209,700
|
$3,365,685 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
167,466
|
$2,687,829 | — | 30 Jun 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.2%
|
146,464
|
$2,350,747 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
130,207
|
$2,089,823 | — | 30 Jun 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.18%
|
127,991
|
$2,054,256 | — | 30 Jun 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.17%
|
120,000
|
$1,926,000 | — | 30 Jun 2023 | |
| Tri Locum Partners LP |
13F
|
Company |
0.15%
|
108,928
|
$1,748,294 | — | 30 Jun 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.15%
|
105,000
|
$1,685,250 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
90,531
|
$1,453,023 | — | 30 Jun 2023 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.11%
|
80,000
|
$1,284,000 | — | 30 Jun 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.11%
|
79,500
|
$1,275,975 | — | 30 Jun 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.1%
|
70,522
|
$1,131,000 | — | 30 Jun 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.1%
|
70,000
|
$1,123,500 | — | 30 Jun 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
68,306
|
$1,096,311 | — | 30 Jun 2023 | |
| Trexquant Investment LP |
13F
|
Company |
0.07%
|
53,474
|
$858,258 | — | 30 Jun 2023 | |
| Crestline Management, LP |
13F
|
Company |
0.06%
|
45,380
|
$728,349 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
43,151
|
$692,573 | — | 30 Jun 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
34,290
|
$550,355 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
33,200
|
$532,860 | — | 30 Jun 2023 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
32,535
|
$522,187 | — | 30 Jun 2023 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.04%
|
32,045
|
$514,322 | — | 30 Jun 2023 | |
| Joanne Curley |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
26,962
|
$485,316 | — | 21 Aug 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
26,231
|
$421,008 | — | 30 Jun 2023 |
Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q3 2023
As of 30 Sep 2023,
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,258,779 shares.
The largest 10 holders included
COMMODORE CAPITAL LP, FMR LLC, Sofinnova Investments, Inc., Kynam Capital Management, LP, Woodline Partners LP, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and Eversept Partners, LP.
This page lists
84
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
76
Q3 2023 holders
84
Holder diff
8
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.